Community Forum

Clinical Trials

Updates On Series
cancer patient

Date and time

December 14, 2021

12:00 PM - 1:00 PM PT



How are technological advances impacting the selection of patients for clinical trials? What's the impact of immunotherapy on cancer treatment? And how is response-to-therapy currently monitored?

Our current understanding of the basic biology of cancer disease is assisting physicians in stratifying patients for select therapies. Join us and learn more.


Event recording



Keith T. Flaherty, M.D.
Director of Clinical Research 
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School

Ze’ev Ronai, Ph.D.
Director and Professor
NCI-Designated Cancer Center
Sanford Burnham Prebys
Jeanne and Gary Herberger Leadership Chair in Cancer Research

Steve Silverstein



Steve Silverstein, M.B.A.
Chair Emeritus, Board of Directors
Melanoma Research Foundation

Cancer Survivor